Abstract
Phage Display Libraries in Sequelization of Autoantibody Signature Analyses in Cancer Immunomics
Highlights
In Partin et al [2], sera from the subjects with low-grade prostate cancer (Gleason score 6 or lower, which is likely insignificant cancer in men with a prostate cancer negative diagnosis) were used as as the control group sera
It is of clinical interest to consider overall usefulness of phage display in comparison with protein microarray strategies
Phage-display and protein microarray performance have not been directly compared in terms of the performance
Summary
In Partin et al [2], sera from the subjects with low-grade prostate cancer (Gleason score 6 or lower, which is likely insignificant cancer in men with a prostate cancer negative diagnosis) were used as as the control group sera. It is of clinical interest to consider overall usefulness of phage display in comparison with protein microarray strategies. Phage-display and protein microarray performance have not been directly compared in terms of the performance.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
